EMA tools to foster development of new and innovative medicines
The European Medicines Agency (EMA) released a new infosheet that provides regulatory and scientific guidance to foster development of new and innovative medicines.
The following tools are available to take the medicne from the early phases in the laboratory to the patient:
Source: http://www.ema.europa.eu/docs/en_GB/document_library/Leaflet/2018/07/WC500251372.pdf
Asphalion has wide experience in these regulatory tools recommended by EMA for the optimal development of your innovative product. We would be glad to support you in any of these activities.
Establish the right strategy by relying on our experts. Contact us at info@asphalion.com
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...
